临床试验

REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness

NCT：NCT07792252 · NOT_YET_RECRUITING

NCT编号NCT07792252

状态NOT_YET_RECRUITING

SponsorYale University (OTHER)

First posted2026-08-28

Last updated2026-09-09

简要摘要

Rejoyn is a Prescription Digital Therapeutic (PDT) for adults with Major Depressive Disorder (MDD). This study aims to evaluate the feasibility, engagement, and clinical context of integrating Rejoyn into standard interventional workflows at the Yale New Haven Hospital Interventional Psychiatry Service (IPS). This is a non-significant risk, observational real-world evidence (RWE) study.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。